The Enterprise Value as of June 2026 (TTM) for Caris Life Sciences, Inc. (CAI) is 4.26B

According to Caris Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.26B. This represents a change of -73.38% compared to the average of 16.00B of the last 4 quarters.

Caris Life Sciences, Inc. (CAI) Historical Enterprise Value (quarterly & annually)

How has CAI Enterprise Value performed in the past?

The mean historical Enterprise Value of Caris Life Sciences, Inc. over the last ten years is 8.03B. The current 4.26B Enterprise Value has changed 5.20% with respect to the historical average. Over the past ten years (40 quarters), CAI's Enterprise Value was at its highest in in the December 2025 quarter at 44.69B. The Enterprise Value was at its lowest in in the March 2024 quarter at 0.

Caris Life Sciences, Inc. (CAI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Caris Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Caris Life Sciences, Inc. (CAI) Average Enterprise Value

How has CAI Enterprise Value performed in the past?

The current Enterprise Value of Caris Life Sciences, Inc. (CAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Caris Life Sciences, Inc. (CAI) Enterprise Value vs. Peers

How is CAI’s Enterprise Value compared to its peers?

Caris Life Sciences, Inc.’s Enterprise Value is less than Jazz Pharmaceuticals plc (18.06B), greater than Atrium Therapeutics, Inc. (-53572208.00), less than Moderna, Inc. (19.19B), less than Cytokinetics, Incorporated (9.89B), less than Madrigal Pharmaceuticals, Inc. (11.20B), less than Halozyme Therapeutics, Inc. (10.08B), less than Merus N.V. (6.52B), less than Abivax S.A. (6.30B), less than Corcept Therapeutics Incorporated (8.80B), less than Rhythm Pharmaceuticals, Inc. (6.23B),

Build a custom stock screener for Caris Life Sciences, Inc. (CAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caris Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Caris Life Sciences, Inc. (CAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Caris Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.